Company Rosa Med Pharm Srl with Fiscal Code 26417088
recorded a turnover of 2024 of
200.310,
with a net profit of
4.771
and having an average number of employees of
3.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Rosa Med Pharm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
298.543
311.151
327.786
323.636
284.550
266.262
208.059
205.480
203.845
200.310
Total Income - EUR
307.768
313.862
332.787
327.540
287.891
271.276
210.740
211.841
205.462
200.495
Total Expenses - EUR
287.347
293.943
299.346
297.441
264.194
244.230
186.906
192.166
175.477
189.708
Gross Profit/Loss - EUR
20.421
19.919
33.441
30.099
23.697
27.046
23.834
19.675
29.985
10.786
Net Profit/Loss - EUR
16.989
16.403
29.840
26.827
20.818
24.944
21.754
17.557
27.931
4.771
Employees
4
4
0
5
5
4
3
3
3
3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -1.2%, from 203.845 euro in the year 2023, to 200.310 euro in 2024.
The Net Profit decreased by -23.003 euro, from 27.931 euro in 2023, to 4.771 in the last year.
Check the financial reports for the company - Rosa Med Pharm Srl
Financial Rating - ROSA MED PHARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Rosa Med Pharm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Rosa Med Pharm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Rosa Med Pharm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Rosa Med Pharm Srl - CUI 26417088
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
9.999
6.598
3.134
3.076
3.017
3.709
4.662
4.441
4.976
4.067
Current Assets
77.469
77.271
91.145
105.624
102.525
119.896
79.841
58.561
77.404
57.373
Inventories
41.907
45.867
34.617
35.389
32.205
24.817
17.319
5.465
18.663
3.897
Receivables
28.293
1.048
45.630
64.699
42.552
48.516
41.966
48.704
37.682
32.416
Cash
7.270
30.356
10.898
5.535
27.767
46.563
20.556
4.391
21.058
21.059
Shareholders Funds
17.045
16.459
29.894
56.173
20.871
45.420
21.804
17.607
45.485
33.964
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
70.423
67.411
64.385
52.527
84.670
78.185
62.698
45.395
36.895
27.476
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
57.373 euro in 2024 which includes Inventories of
3.897 euro, Receivables of
32.416 euro and cash availability of
21.059 euro.
The company's Equity was valued at
33.964 euro, while total Liabilities amounted to
27.476 euro.
Equity decreased by -11.267 euro, from 45.485 euro in 2023, to 33.964 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Rosa Med Pharm Srl